135 related articles for article (PubMed ID: 30652537)
21. IOM report calls for sweeping changes in cancer clinical trials.
Boughton B
Clin Transl Sci; 2010 Aug; 3(4):129. PubMed ID: 20799431
[No Abstract] [Full Text] [Related]
22. Development of Novel Radiosensitizers through the National Cancer Institute's Small Business Innovation Research Program.
Zakeri K; Narayanan D; Prasanna PGS; Vikram B; Buchsbaum JC
Radiat Res; 2020 May; 193(5):425-434. PubMed ID: 32216707
[TBL] [Abstract][Full Text] [Related]
23. IOM report calls for a more streamlined, faster cancer cooperative trials program.
Kuehn BM
JAMA; 2010 Jun; 303(21):2126-7. PubMed ID: 20516407
[No Abstract] [Full Text] [Related]
24. The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.
Song PH; Reiter KL; Weiner BJ; Minasian L; McAlearney AS
Health Care Manage Rev; 2013; 38(4):284-94. PubMed ID: 23044836
[TBL] [Abstract][Full Text] [Related]
25. Creation of community-based research capabilities in the neighborhood cancer care cooperative: administrative infrastructure, program initiatives, and evaluation priorities.
Morgenlander KH; Schenken LL; Heron DE; Klewien B; Lin CJ; Block B; Schwaderer K; McNelly SL
Soc Work Public Health; 2009; 24(4):305-29. PubMed ID: 19517298
[TBL] [Abstract][Full Text] [Related]
26. The National Cancer Institute's Clinical Trials Innovation Unit.
Morris MJ; Prindiville S
Clin Adv Hematol Oncol; 2023 Dec; 21(12):663-665. PubMed ID: 38039060
[No Abstract] [Full Text] [Related]
27. Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.
Szczepanek CM; Hurley P; Good MJ; Denicoff A; Willenberg K; Dawson C; Kurbegov D
J Oncol Pract; 2017 Jun; 13(6):395-400. PubMed ID: 28481681
[TBL] [Abstract][Full Text] [Related]
28. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
29. Between prevention and therapy: Gio Batta Gori and the National Cancer Institute's Diet, Nutrition and Cancer Programme, 1974-1978.
Cantor D
Med Hist; 2012 Oct; 56(4):531-61. PubMed ID: 23112384
[TBL] [Abstract][Full Text] [Related]
30. National Cancer Institute partnerships in quality-of-care research.
Clauser SB
Cancer Control; 2009 Oct; 16(4):283-92. PubMed ID: 19910914
[TBL] [Abstract][Full Text] [Related]
31. National Cancer Institute's Small Grants Program for behavioral research in cancer control boosts careers for new investigators and fulfills NIH research priorities.
Chollette VY; Crowley K
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2459-63. PubMed ID: 18006937
[TBL] [Abstract][Full Text] [Related]
32. The Cancer Informatics Infrastructure (CII): an architecture for translating clinical research into patient care.
Silva JS; Ball MJ; Douglas JV
Stud Health Technol Inform; 2001; 84(Pt 1):114-7. PubMed ID: 11604717
[TBL] [Abstract][Full Text] [Related]
33. Speeding implementation in cancer: The National Cancer Institute's Implementation Science Centers in Cancer Control.
Oh AY; Emmons KM; Brownson RC; Glasgow RE; Foley KL; Lewis CC; Schnoll R; Huguet N; Caplon A; Chambers DA
J Natl Cancer Inst; 2023 Feb; 115(2):131-138. PubMed ID: 36315080
[TBL] [Abstract][Full Text] [Related]
34. Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute's cardiovascular clinical trials.
Pemberton VL; Evans F; Gulin J; Rosenberg E; Addou E; Burns KM; Gordon DJ; Pearson GD; Kaltman JR
Clin Trials; 2018 Oct; 15(5):444-451. PubMed ID: 30084662
[TBL] [Abstract][Full Text] [Related]
35. Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.
Bando H; Takebe N
Jpn J Clin Oncol; 2015 Nov; 45(11):1001-6. PubMed ID: 26423340
[TBL] [Abstract][Full Text] [Related]
36. Overhaul of NCI Clinical Trial System Still in Progress.
Nicholas J
J Natl Cancer Inst; 2013 Aug; 105(15):1067-8. PubMed ID: 23884052
[No Abstract] [Full Text] [Related]
37. The Cancer Informatics Infrastructure: a new initiative of the National Cancer Institute.
Hubbard SM; Setser A
Semin Oncol Nurs; 2001 Feb; 17(1):55-61. PubMed ID: 11236366
[TBL] [Abstract][Full Text] [Related]
38. Application of nanotechnology in cancer research: review of progress in the National Cancer Institute's Alliance for Nanotechnology.
Ehdaie B
Int J Biol Sci; 2007 Jan; 3(2):108-10. PubMed ID: 17304339
[No Abstract] [Full Text] [Related]
39. Cancer clinical trials--a chronic but curable crisis.
Young RC
N Engl J Med; 2010 Jul; 363(4):306-9. PubMed ID: 20554976
[No Abstract] [Full Text] [Related]
40. The National Cancer Institute's Cancer Information Service: a premiere cancer information and education resource for the nation.
Bright MA
J Cancer Educ; 2007; 22(1 Suppl):S2-7. PubMed ID: 17571997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
